Information
-
Trademark
-
97748253
-
Serial Number
97748253
-
Registration Number
7518883
-
International Classifications
-
Filing Date
January 10, 2023
2 years ago
-
Registration Date
October 01, 2024
8 months ago
-
Transaction Date
October 01, 2024
8 months ago
-
Status Date
October 01, 2024
8 months ago
-
Published for Opposition Date
July 16, 2024
10 months ago
-
Location Date
September 30, 2024
8 months ago
-
Status Code
700
-
Current Location
FILE REPOSITORY (FRANCONIA)
Employee Name
GAGNER, NICHOLAS
-
Attorney Docket Number
TOYO-0019/US
Attorney Name
Mary Margaret L. O'Donnell
-
Owners
Mark Drawing Code
4
Mark Identification
NIPPON CHEMIPHAR
Case File Statements
- GS0051: Pharmaceutical preparations for Cardiovascular Disorders, Genitourinary Disorders, Gynecological diseases, Cancer and cancer supportive care, Eye Disorders, Neurologic Disorders, Psychiatric Disorders, Endocrine and Metabolic Disorders, Allergic Disorders, Gastrointestinal Disorders, Immune Diseases and Autoimmune Diseases, Respiratory Diseases, Musculoskeletal and Connective Tissue Disorders, Infectious Diseases, Dermatologic Disorders, Hematological Disorder, Inflammatory Diseases, Ear, Nose, Dental and Throat Disorders, Hepatic and Biliary Disorders, Kidney Diseases, Medicines for improving sleep, Medicines for controlling sickness from drinking, Medicines for controlling hangovers; Obstetric medicines being medical preparations for the treatment of endometriosis or adenomyosis; local, topical, general, inhalant anesthetic; Sedatives; Analgesic drugs; Alkalinizing agents being preparations for the lowering pH levels in patients; Anti-aging agents being pharmaceutical preparations for reducing the effects of aging in patients; reagent paper for medical purposes; pharmaceutical preparations for reducing pain, reducing inflammation; pharmaceutical preparations and substances with antipyretic properties anti-inflammatories and analgesic properties for the treatment of nociceptive pains, the treatment of neuropathic pains, the treatment of visceral pains, the treatment of rheumatoid arthritis, the treatment of low back pain, and the treatment of after surgery, trauma, and tooth extraction; pharmaceutical preparations for the treatment of gout and hyperuricemia; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations and substances for the treatment of cancer; Hygiene agent, namely, medical cleanser for skin and wounds; Eye patches and skin patches for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation; medicated ointments for treating dermatological conditions; Infusion drug for medical purposes, namely, pharmaceutical preparations for reducing pain, reducing inflammation that need to be administered gradually intravenously; Diagnostic agents and reagents for medical use; diagnostic reagents for medical purposes; Medical diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; In vitro diagnostic reagent for medical use; In vitro diagnostic reagents kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in determining allergies; medical oiled paper; Drug delivery agents in the form of wafers for wrapping powdered pharmaceuticals for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages spray; Breast-nursing pads; cotton swabs for medical use; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Vitamin fortified beverages for babies for medical purposes; food for babies; dietary-supplements-for-animals other than drugs; Semen for artificial insemination; ferments for pharmaceutical purposes; Food supplements, namely, antioxidant pills; dietary supplements for anti-aging immune system for humans; appetite suppressant pills; dietary fiber to aid digestion; pharmaceutical preparations for treating dry skin; Pharmaceutical preparations being medical application cream pharmaceuticals for treating skin conditions; pharmaceutical preparations for skin care; Nasal sprays for medical purposes
- TR0010: The English translation of NIPPON in the mark is Japan.
- GS0011: Diagnostic reagents for medical research; Diagnostic reagent kits consisting of chemical reagents, cell culture reagents, biochemical reagents for medical research
- DS0000: "NIPPON"
- GS0101: Medical apparatus and instruments, namely, medical devices for use in diagnosing allergies; Medical diagnostic apparatus and instruments for diagnostic for immunotherapy medical purposes; Medical diagnostic apparatus and instruments, namely, medical devices for use in diagnosing allergies; apparatus for use in medical purpose for identifying allergens causing allergy, namely, medical devices for use in diagnosing allergies; medical diagnostic apparatus for testing and quantifying the amount of allergen-specific antibody; Genetic testing apparatus for medical purposes; medical measuring apparatus, namely, medical apparatus for measuring skin hydration; Medical diagnostic apparatus for measuring, testing and analyzing specimens reacted with diagnostic reagents; medical diagnostic apparatus, namely, immunoassay analyzer being medical diagnostic apparatus for testing for viruses; mobile medical apparatus for enzyme-linked immunosorbent assay, namely, medical diagnostic apparatus for testing for blood protein, DNA for allergy screening; medical diagnostic apparatus for testing and measuring specific immunoglobulin E (IgE) antibodies; Sanitary masks for personal use; dental materials being dental implants
Case File Event Statements
-
1/13/2023 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/31/2023 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
10/3/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/5/2023 - a year ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/5/2023 - a year ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
10/5/2023 - a year ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/4/2024 - a year ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
1/4/2024 - a year ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
1/5/2024 - a year ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/23/2024 - a year ago
10 - FINAL REFUSAL WRITTEN
Type: CNFR
-
2/23/2024 - a year ago
11 - FINAL REFUSAL E-MAILED
Type: GNFR
-
2/23/2024 - a year ago
12 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
5/22/2024 - a year ago
14 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/22/2024 - a year ago
13 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
5/22/2024 - a year ago
16 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/22/2024 - a year ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/23/2024 - a year ago
18 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/23/2024 - a year ago
17 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
5/23/2024 - a year ago
19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/23/2024 - a year ago
20 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/28/2024 - a year ago
21 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/30/2024 - a year ago
22 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Type: ERRR
-
6/26/2024 - 11 months ago
23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
7/16/2024 - 10 months ago
24 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/16/2024 - 10 months ago
25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/16/2024 - 10 months ago
26 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
7/16/2024 - 10 months ago
27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
10/1/2024 - 8 months ago
28 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
10/1/2024 - 8 months ago
29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC